XML 23 R7.htm IDEA: XBRL DOCUMENT v3.24.1
Statements of Cash Flows - USD ($)
9 Months Ended 12 Months Ended
Dec. 31, 2022
[1]
Dec. 31, 2023
Mar. 31, 2022
Cash flows from operating activities      
Net increase (decrease) in net assets resulting from operations $ 1,923,639 $ 7,340,108 $ (563,365)
Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by (used in) operating activities:      
Net realized (gain) loss from investments 0 210,767 0
Net change in unrealized (appreciation) depreciation from investments 273,348 (922,031) 0
Net (accretion of discounts) and amortization of premiums (165,398) (810,554) 0
Purchase of investments (50,362,500) (8,442,000) 0
PIK interest capitalized 0 (115,725) 0
Proceeds from sales of investments and principal repayments 0 6,214,093 0
(Increase)/Decrease in operating assets:      
Interest receivable (1,549,867) (196,279) (9,215)
Other assets 0 (50,000) 0
Prepaid expenses 224,189 (6,953) (256,512)
Deferred offering costs 0 0 276,256
Increase/(Decrease) in operating liabilities:      
Income-based incentive fees payable 0 1,511,253 0
Management fee payable 170,965 86,156 0
Capital gains incentive fees payable 0 87,583 0
Legal fees payable 8,232 42,609 33,983
Transaction fees payable related to the Loan Portfolio Acquisition 0 711,264 0
Valuation fees payables 0 24,675 0
Administrator fees payable 10,155 29,157 47,151
Audit fees payable 0 73,998 40,000
Director fees payable 7,679 62,711 24,370
Professional fees payable 28,744 (11,511) 0
Other payables 8,305 (19,841) 25,359
Due to affiliate (48) (37) 85
Excise tax payable 80,566 (69,911) 0
Offering cost payable (264,581) 0 (11,675)
Organizational costs payable (34,168) 0 (115,547)
Net cash provided by (used in) operating activities (49,640,740) 5,749,532 (509,110)
Cash flows from financing activities      
Issuance of common stock, net of offering cost 0 0 85,275,170
Distributions paid 0 (8,263,217) 0
Net cash provided by (used in) financing activities 0 (8,263,217) 85,275,170
Net increase (decrease) in cash and cash equivalents (49,640,740) (2,513,685) 84,766,060
Cash and cash equivalents, beginning of period 84,766,060 35,125,320 [1] 0
Cash and cash equivalents, end of period 35,125,320 32,611,635 84,766,060 [1]
Supplemental and non-cash financing activities      
Reinvestment of dividend distributions $ 0 $ 2,318 $ 0
[1] On November 8, 2022, our Board of Directors approved a change in our fiscal year end from March 31 to December 31.